XOMA Corp (XOMA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $26.76
• Market Cap: $331.12M
• P/E Ratio: 36.14
• EPS: $0.74
• 52-Week High: $39.92
• 52-Week Low: $18.35

Market Sentiment

XOMA Corp currently has a Neutral sentiment score of 0.11.

About XOMA Corp

XOMA Corporation is a biotechnology firm headquartered in Emeryville, California, specializing in the discovery and development of innovative therapeutic candidates through its distinctive royalty aggregation model. By collaborating with biopharmaceutical companies, XOMA advances treatments across multiple disease areas, capitalizing on its expertise in antibody development and robust clinical and regulatory programs. With operations extending into the United States, Europe, and the Asia Paci...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for XOMA Corp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does XOMA pay dividends?

XOMA Corp (XOMA) does not currently pay a regular dividend.

What is XOMA's P/E ratio?

XOMA Corp has a price-to-earnings (P/E) ratio of 36.14.

What is XOMA's market cap?

XOMA Corp (XOMA) has a market capitalization of $331.12M with a current stock price of $26.76.